# ICICI Prudential Nifty Pharma ETF

ICICI Prudential Asset Management Company Limited · Exchange Traded · ETF

Full page with charts: https://discovermf.com/funds/icici-prudential-nifty-pharma-etf-154804
Figures as of 3 Nov 2026, from DiscoverMF. Information, not investment advice. Past returns do not indicate future returns. Mutual fund investments are subject to market risks; read all scheme-related documents carefully.

## In short

- **What it invests in:** Follows an index or a price, bought and sold like a share.
- **How bumpy:** Very high: big ups and downs, sometimes sharp falls. Its biggest fall in the last 3 years was 0.1%.
- **Expense ratio:** 0.25% a year. Similar funds: 0.25% on average.
- **Fees and minimums:** A fee may apply if you sell soon after buying; the full terms are under Cost.

Past returns do not tell you future returns.

## Key facts

- **NAV:** ₹27.20 on 3 Nov 2026
- **Fund size:** ₹6.5 cr (2 Nov 2026)
- **Expense ratio:** 0.25% a year (typical in its category 0.25%)
- **Riskometer:** Very High
- **Benchmark:** Nifty Pharma TRI
- **Category:** [Exchange Traded](https://discovermf.com/categories/exchange-traded.md)
- **Fund house:** [ICICI Prudential Asset Management Company Limited](https://discovermf.com/fund-houses/icici-prudential)
- **Launched:** 12 Oct 2026
- **Exit load:** Entry Load nil. Exit Load: There will be no exit load for units sold through the secondary market on the stock exchanges where the Scheme will be listed. Currently, the Scheme is proposed to be listed on BSE and NSE. Investors shall note that the brokerage on sales of the units of the scheme on the stock exchanges shall be borne by the investors. However, during the process of creation/ redemption there may be transaction costs & /or other incidental expenses(forming part of the Cash Compon
- **Minimum investment:** ₹1,000 to start
- **AMFI scheme code:** 154804

## Returns

| Period | Fund | Category average | Benchmark | Rank in category |
| --- | --- | --- | --- | --- |
| 1 month | — | — | — | — |
| 3 months | — | — | — | — |
| 6 months | — | — | — | — |
| 1 year | — | -1.9% | +22.0% | — |
| 3 years (a year) | — | +11.6% | +23.1% | — |
| 5 years (a year) | — | +8.8% | +15.2% | — |
| Since launch (a year) | — | — | — | — |

## Risk

| Measure | Fund | Category average |
| --- | --- | --- |
| Volatility, last year | 11.6% | 15.8% |
| Worst fall, last year | -0.1% | — |
| Worst fall, last 3 years | -0.1% | — |
| Sharpe ratio, 3 years | — | — |
| Sortino ratio, 3 years | — | — |
| Beta, 3 years | — | — |
| Alpha, 3 years | — | — |

## Objective

The objective of the investment scheme is to provide returns before expenses that closely correspond to the total return of the underlying index, subject to tracking errors. However, there can be no assurance or guarantee that the investment objective of the Scheme would be achieved.